Financial Statements

Bayer Group Consolidated Balance Sheets

	Sept. 30, 2007	Sept. 30, 2008	Dec. 31, 2007
€ million
Noncurrent assets
Goodwill	8,336	8,646	8,215
Other intangible assets	14,685	14,234	14,555
Property, plant and equipment	8,664	9,200	8,819
Investments in associates	481	475	484
Other financial assets	1,104	1,049	1,127
Other receivables	488	1,190	667
Deferred taxes	808	295	845
	34,566	35,089	34,712
Current assets
Inventories	6,315	6,696	6,217
Trade accounts receivable	6,355	6,586	5,830
Other financial assets	312	327	335
Other receivables	1,524	1,325	1,461
Claims for income tax refunds	240	362	208
Cash and cash equivalents	2,381	2,281	2,531
Assets held for sale and discontinued operations	-	-	84
	17,127	17,577	16,666

Total assets	51,693	52,666	51,378

Stockholders’ equity
Capital stock of Bayer AG	1,957	1,957	1,957
Capital reserves of Bayer AG	4,028	4,028	4,028
Other reserves	10,937	12,245	10,749
	16,922	18,230	16,734
Equity attributable to minority interest	86	80	87
	17,008	18,310	16,821

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	5,268	4,442	5,501
Other provisions	1,596	1,503	1,166
Financial liabilities	13,307	9,420	12,911
Other liabilities	502	633	501
Deferred taxes	3,632	3,638	3,866
	24,305	19,636	23,945
Current liabilities
Other provisions	4,080	3,717	3,754
Financial liabilities	1,298	6,004	1,287
Trade accounts payable	2,219	2,266	2,466
Income tax liabilities	104	242	56
Other liabilities	2,679	2,478	2,873
Liabilities directly related to assets held for sale and discontinued operations	-	13	176
	10,380	14,720	10,612

Total stockholders’ equity and liabilities	51,693	52,666	51,378

2007 figures reclassified